Skip to main content
Caplight Logo









Sapphiros

Sapphiros

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://sapphiros.com/

Last Round

Series B

Jan 4, 2024

Total Funding Raised

$41.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sapphiros is a consumer diagnostics company that develops and manufactures point-of-care and at-home diagnostic technologies, including lateral flow tests, molecular detection platforms, and patch-based collection systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Smart Manufacturing, Sensors

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

point-of-care diagnosticslateral flow testsmolecular diagnosticsPOC testingat-home testingcontract manufacturingbiosensorsconnected diagnosticsdigital healthprinted electronicsnucleic acid testingdiagnostic hardwarerapid testingmedtechpandemic preparedness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sapphiros Comparables

Compare Sapphiros with similar companies based on industry and business-model similarity.

Sapphiros comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aptitude Medical
82%
Visby Medical
78%
OraSure Technologies Inc
77%

Sapphiros Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 4, 2024
GrantApr 17, 2023
Corporate FundingJul 21, 2021

Key People

Founding team and executive leadership

Mark Gladwell

President and Chief Executive Officer

Executive Team

Jackson McAdam

Chief Financial Officer

Executive Team

Sapphiros Investors

Notable investors and investment history

Sapphiros investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
NIH RADxGrant
KKRCorporate Funding
NeoentaCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 51% MoM, reaching 1.5K.

  • Feb 27, 2024

    Grew 19% QoQ, from 42 to 50 employees.

Sapphiros Filings

Explore SEC and related filing metadata, where available.

Sapphiros filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sapphiros's valuation, stock price, and market status.

Is Sapphiros a public or private company?

Sapphiros is a private company.

What is the current stock price of Sapphiros?

Sapphiros is a private company with no public stock price. No recent secondary market data is available.

How much is Sapphiros worth (valuation)?

Valuation information for Sapphiros is not publicly available.

Can I buy Sapphiros stock?

Sapphiros shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sapphiros's last funding round?

Sapphiros's most recent funding round was Series B on January 4, 2024.

Who are the main investors in Sapphiros?

Key investors in Sapphiros include KKR.

Will Sapphiros IPO soon?

No public IPO plans have been announced for Sapphiros.

How can I track Sapphiros secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sapphiros's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range18
Year Founded2017
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?